| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090721 Mucin-containing delivery vehicle for the transport of biomolecules |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090715 Method for the preparation of a viral vector by inter-molecular homologous recombination |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090658 Diagnosing connective tissue defects; obtain sample, screen sample for the presence of degradation protein, amplified concentrations of protein indicate connective tissue defects |
| 07/11/2002 | US20020090657 Detecting preferential binding particle in sample; obtain cell, incubate with modulator, monitor forming of complex, compare to control, reduction in complex formation indicates bound receptor |
| 07/11/2002 | US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090382 Antiviral compounds and methods |
| 07/11/2002 | US20020090381 System for controlling immune system response to antigen |
| 07/11/2002 | US20020090379 Poviding self-protein analog by molecular biological means by substitution of one or more peptide fragments of self-protein by corresponding number of peptides known to contain immunodominant foreign T-cell epitopes |
| 07/11/2002 | US20020090378 In ovo vaccination against coccidiosis |
| 07/11/2002 | US20020090377 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/11/2002 | US20020090375 Stratified and cryogenically stored vaccines, process for their preparation |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090372 Isolated polypeptides used in vaccines and pharmaceuticals for treatment of prostate cancer |
| 07/11/2002 | US20020090371 Orally or enterally administering to the mammal an effective immunosuppressive dose of a plant material derived from a plant transformant capable of producing antigen or an immunosuppressive fragment or its derivative |
| 07/11/2002 | US20020090370 Novel porcine protein and uses thereof |
| 07/11/2002 | US20020090366 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | DE10065986A1 Pharmaceutical formulation, especially a vaccine, e.g. against polio or parvovirus, contains proteins, peptides and/or nucleic acids as well as compatible solutes |
| 07/11/2002 | CA2708949A1 Immunizing compositions and methods of use |
| 07/11/2002 | CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | CA2433967A1 Anti-inflammatory use of polycationic compounds |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433794A1 Uses for polycationic compounds as vaccine adjuvants |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433781A1 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 07/11/2002 | CA2433561A1 Compositions including gram negative siderophore receptor proteins and methods of use |
| 07/11/2002 | CA2433361A1 Controlled release systems for polymers |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432488A1 Use of tinospora extract in the treatment of immune system-modulated disorders |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2431662A1 A method for the manufacture of compositions containing low concentrations of salts |
| 07/11/2002 | CA2429636A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 07/10/2002 | EP1221488A1 Stress proteins and uses therefor |
| 07/10/2002 | EP1221487A2 Polynucleotide molecules encoding neospora proteins |
| 07/10/2002 | EP1221486A2 Polynucleotide molecules encoding neospora proteins |
| 07/10/2002 | EP1221485A2 Polynucleotide molecules encoding neospora proteins |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221317A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220924A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220923A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIVES |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220908A2 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220686A2 Vaccine against neisseria infection |
| 07/10/2002 | EP1220659A1 Pharmaceutical products and methods of fabrication therefor |
| 07/10/2002 | EP1220612A1 Pediculocidal and veterinary compositions |
| 07/10/2002 | EP1220611A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 07/10/2002 | EP0812206B1 Cd40 binding protein for stimulating an immune response |
| 07/10/2002 | CN1358227A Production of the lipidated form of the peptido glycon-associated lipoproteins of gram-negative bacteria |
| 07/10/2002 | CN1358198A Chimeric polypeptides, method for production and uses thereof |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358101A Method of controlling the qualities of attenuated pox vaccine |
| 07/10/2002 | CN1358100A Manufacturing method for intravenous immune globulin and resul tant product |
| 07/10/2002 | CN1358099A Utilization of aminopeptidase inhibitor |
| 07/10/2002 | CN1357385A Anticancer vaccine |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087177C Vaccine adjuvants |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/10/2002 | CN1087175C Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 07/09/2002 | US6417341 Malaria merozoite antigen subunit vaccine |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6417165 NY-ESO-1-peptide derivatives, and uses thereof |
| 07/09/2002 | US6416996 Hepatitis b virus genome |
| 07/09/2002 | US6416989 Isolated polypeptide |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416972 Purified hybrid nucleic acid |
| 07/09/2002 | US6416968 Methods of inhibiting Helicobacter pylori |
| 07/09/2002 | US6416947 Vaccine adjuvant and vaccine method |
| 07/09/2002 | US6416946 Contacting sample with composition comprising reagent consisting essentially of combination of hepatitis c type specific epitopes under conditions which allow formation of epitope-antibody complexes, assaying for presence of complexes |
| 07/09/2002 | US6416944 Methods of typing hepatitis C virus and reagents for use therein |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | US6416764 Bovine viral diarrhea virus |
| 07/09/2002 | US6416763 Recombinant nonstructural protein subunit vaccine against flaviviral infection |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | CA2077434C Antigenic proteins of borrelia burgdorferi |
| 07/09/2002 | CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 |
| 07/09/2002 | CA1341375C Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
| 07/09/2002 | CA1341374C Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2 |